Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry

Clinical and Experimental Metastasis

Volumn 19, Issue 4, 2002, Pages 319-326

  Wu, Weiguo ^a   Tang, Ximing ^a   Hu, Wei ^a   Lotan, Reuben ^a   Hong, Waun Ki ^a   Mao, Li ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

HNSCC; Mass spectrometry; Metastasis; Two dimensional electrophoresis

Indexed keywords

ENOLASE; LIPOCORTIN 1; LIPOCORTIN 2; TRYPSIN;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MASS SPECTROMETRY; METASTASIS; PEPTIDE MAPPING; PROTEIN DEGRADATION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANNEXIN A1; ANNEXIN A2; CALCIUM-BINDING PROTEINS; CARCINOMA, SQUAMOUS CELL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PEPTIDE MAPPING; PHOSPHOPYRUVATE HYDRATASE; PROTEOME; SUBTRACTION TECHNIQUE; TUMOR CELLS, CULTURED;

EID: 0036280779     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015515119300     Document Type: Article

References (47)

1. Cancer Statistics, 2000
2. Proteomics to study genes and genomes
3. Cancer proteomics: From identification of novel markers to creation of artifical learning models for tumor classification
4. Proteomic analysis
5. Mass spectrometry: A tool for the identification of proteins separated by gels
6. Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: A novel strategy for identifying metaplastic lesions
7. Psoriasin (S100A7): A putative urinary marker for the follow-up of patients with bladder squamous cell carcinomas
8. Bladder squamous cell carcinoma biomarkers derived from proteomics
9. Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties
10. Renal cell carcinoma and normal kidney protein expression
11. Analysis of polypeptide expression in benign and malignant human breast lesions: Down-regulation of cytokeratins
12. Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas
13. Two-dimensional gel analysis of protein expression in ovarian tumors shows a low degree of intratumoral heterogeneity
14. Tissue-specific microdissection coupled with ProteinChip array technologies: Applications in cancer research
15. Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250
16. Annexins: The problem of assessing the biological role for a gene family of multifunctional calcium-and phospholipid-binding proteins
17. Annexin I is a stress protein induced by heat, oxidative stress and a sulfhydryl-reactive agent
18. Annexins: From structure to function
19. Candidate metastasis-associated genes of the rat 13762NF mammary adenocareinoma
20. Elevated levels of annexin I protein in vitro and in vivo in rat and human mammary adenocarcinoma
21. Increased expression of annexin I and thioredoxin detected by two-dimensional gel electrophoresis of drug-resistant human stomach cancer cells
22. Enhanced expression of lipocontin-I as a new immunosuppressive protein in cancer patients and its influence on reduced in vitro peripheral blood lymphocyte response to mitogens
23. Cell surface complex of cathepsin B/annexin II tetramer in malignant progression
24. Annexin II and regulation of cell surface fibrinolysis
25. Extracellular annexin II
26. Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells
27. Regulation of plasmin activity by annexin II tetramen
28. The role of annexin II tetramer in the activation of plasminogen
29. Annexin II: A mediator of the plasmin/plasminogen activator system
30. Role of annexin II tetramer in plasminogen activation
31. The plasminogen activator system in pancreas cancer: Role of t-PA in the invasive potential in vitro
32. Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers
33. Expression of annexins on the surfaces of non-metastatic and metastatic human and rodent tumor cells
34. Annexin II tetramer inhibits plasmin-dependent fibrinolysis
35. Collagen-binding proteins of mammary epithelial cells are related to Ca2(+)- and phospholipid-binding annexins
36. Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C
37. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation
38. Mapping of a regulatory important site for protein kinase C phosphorylation in the N-terminal domain of annexin II
39. Hypoxia response elements in the aldolase A, enolase 1, and iactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1
40. Role of HIF-I as a transcription factor involved in embryonic development, cancer progression and apoptosis
41. Overexpression of hypoxia-inducible factor lalpha in common human cancers and their metastases
42. The role of an enolase-related molecule in plasminogen binding to cells
43. Role of cell-surface lysines in plasminogen binding to cells: Identification of alpha-enolase as a candidate plasminogen receptor
44. The CREC family, a novel family of multiple EF-hand, low-affinity Ca(2+)-binding proteins localized to the secretory pathway of mammalian cells
45. Differential display of reticulocalbin in the highly invasive cell line, MDA-MB-435, versus the poorly invasive cell line, MCF-7
46. Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein